Michaeleen Doucleff
Michaeleen Doucleff is a reporter for NPR's Science Desk. She reports for the radio and the Web for NPR's global health and development blog, Goats and Soda. Doucleff focuses on disease outbreaks, drug development, and trends in global health.
In 2014, Doucleff was part of the team that earned a George Foster Peabody award for its coverage of the Ebola outbreak in West Africa. For the series, Doucleff reported on how the epidemic ravaged maternal health and how the virus spreads through the air. In 2015, Doucleff and Senior Producer Jane Greenhalgh reported on the extreme prejudices faced by young women in Nepal when they're menstruating. Their story was the second most popular one on the NPR website in 2015 and contributed to the NPR series on 15-year-old girls around the world, which won two Gracie Awards.
As a science journalist, Doucleff has reported on a broad range of topics, from vaccination fears and the microbiome to beer biophysics and dog psychology.
Before coming to NPR in 2012, Doucleff was an editor at the journal Cell, where she wrote about the science behind pop culture. Doucleff has a doctorate in chemistry from the University of Berkeley, California, and a master's degree in viticulture and enology from the University of California, Davis.
-
It appears to be 50% more infectious, and researchers predict the new coronavirus variant could start to dominate in the U.S. by March. The time to prepare is now, they say. -
The U.K. is struggling to stop a more contagious version of the coronavirus. NPR discusses what might happen if the variant spreads across the U.S.
-
Health experts are hopeful that vaccines will stop the coronavirus outbreak in the U.S. But what about the rest of the world?
-
With new variant in the coronavirus cropping up in several states, we take a look at how viruses mutate and how those mutations can make the coronavirus more contagious.
-
Mathematical modeling suggests that the mutations in this variant make the virus more transmissible. What does that mean for preventive measures — and the new vaccines?
-
There's cause for concern. But how concerned should we be? Here's a rundown of the current thinking on key issues as transmission, severity of disease — and effectiveness of vaccines.
-
The European Center for Disease Prevention and Control says the COVID-19 variant spreading across England appears to be more contagious. Scientists examine what that means for the rest of the world.
-
Dr. Chizoba Barbara Wonodi of Johns Hopkins University explains why a strategy to vaccinate everyone may not be the best approach to fighting the virus in lower-income countries like Nigeria.
-
Experts say low-risk people in the U.S. will likely be immunized before many high-risk people in poor countries.
-
At least three coronavirus vaccines have been deemed effective. Some Western countries will start vaccination as early as this month. But it's unclear when less wealthy nations will get the vaccines.
